Rosanna Mezzapelle
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Fibroblast-like cells in mesothelioma can derive from tumor cells.
Journal: Cell death and differentiation
Published: November 16, 2024
In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo.
Journal: Cell death & disease
Published: October 10, 2023
CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy.
Journal: Cancers
Published: April 11, 2022
Use of an antagonist of HMGB1 in mice affected by malignant mesothelioma: a preliminary ultrasound and optical imaging study.
Journal: European radiology experimental
Published: August 07, 2021
Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance.
Journal: Cell death & disease
Published: July 23, 2021
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration.
Journal: Frontiers in immunology
Published: May 11, 2020
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma.
Journal: EMBO molecular medicine
Published: March 14, 2020
Stress and Alarmins. Report from the 9th iD&EAs meeting.
Journal: Cell death & disease
Published: November 12, 2019
Diflunisal targets the HMGB1/CXCL12 heterocomplex and blocks immune cell recruitment.
Journal: EMBO reports
Published: January 25, 2019
High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair.
Journal: Immunological reviews
Published: October 14, 2017
Last Updated: 09/26/2026